This is a preprint.
Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization
- PMID: 38076938
- PMCID: PMC10705253
- DOI: 10.1101/2023.01.30.523509
Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization
Update in
-
Normative modelling of brain morphometry across the lifespan with CentileBrain: algorithm benchmarking and model optimisation.Lancet Digit Health. 2024 Mar;6(3):e211-e221. doi: 10.1016/S2589-7500(23)00250-9. Lancet Digit Health. 2024. PMID: 38395541 Free PMC article. Review.
Abstract
We present an empirically benchmarked framework for sex-specific normative modeling of brain morphometry that can inform about the biological and behavioral significance of deviations from typical age-related neuroanatomical changes and support future study designs. This framework was developed using regional morphometric data from 37,407 healthy individuals (53% female; aged 3-90 years) following a comparative evaluation of eight algorithms and multiple covariate combinations pertaining to image acquisition and quality, parcellation software versions, global neuroimaging measures, and longitudinal stability. The Multivariate Factorial Polynomial Regression (MFPR) emerged as the preferred algorithm optimized using nonlinear polynomials for age and linear effects of global measures as covariates. The MFPR models showed excellent accuracy across the lifespan and within distinct age-bins, and longitudinal stability over a 2-year period. The performance of all MFPR models plateaued at sample sizes exceeding 3,000 study participants. The model and scripts described here are freely available through CentileBrain (https://centilebrain.org/).
Conflict of interest statement
Declaration of interests SSH is supported by NIH National Institute of Mental Health (T32MH122394), and received a travel award from the Society of Biological Psychiatry to attend the annual meeting in 2023. HB declares an institutional grant from the National Health and Medical Research Council; has received compensation for being on an advisory board or a consultant to Biogen, Eisai, Eli Lilly, Roche, and Skin2Neuron; payment for being on the Cranbrook Care Medical Advisory Board, and honoraria for being on the Montefiore Homes Clinical Advisory Board. RMB and HEHP declare partial funding through the Geestkracht programme of the Dutch Health Research Council (Zon-Mw, grant No 10-000-1001), and matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ Ingeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord Holland Noord. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia psycho-medical center The Hague. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGzE, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh voor Geestelijke Gezondheid, Mondriaan, Virenze riagg, Zuyderland GGZ, MET ggz, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Utrecht: University Medical Center Utrecht and the mental health institutions Altrecht, GGZ Centraal and Delta), Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO 51.02.061 to H.H., NWO 51.02.062 to D. B., NWO–NIHC Programs of excellence 433-09-220 to H.H., NWO-MagW 480-04-004 to D. B., and NWO/SPI 56-464-14192 to D.B.); FP7 Ideas: European Research Council (ERC-230374 to D. B.); and Universiteit Utrecht (High Potential Grant to H. H.). RB declares funding by NIH National Institute on Aging (R01AG067420); compensation for being on the scientific advisory board from Alkermes and Cognito Therapeutics with no conflict to the present work; honoraria from academic institutions for talks all under $1000 and $1000 for speaking at MGH/HMS course; travel fees for services to attend the annual meeting from the Simons Foundation; serves as a Director on the Simons Foundation collaborative initiative on aging (SCPAB); is a paid scientific advisory board member for philanthropic grants for The Foundation for OCD Research and the Klarman Family Foundation. BF has received educational speaking fees from Medice. DG reports funding from the NIH. UD is funded through the German Research Foundation (DFG; DA 1151/9- 1, DA 1151/10- 1, DA 1151/11- 1). GS declares funding from the European Commission, DFG, and NSFC. CKT has received grants from the Research Council of Norway and the Norwegian Regional Health Authority, unrelated to the current work. HW reports funding from the German Research Foundation (WA 1539/11-1). NJ reports funding from the NIH and compensation from the International Neuropsychological Society. PT declares a grant from the NIH and travel funded by NIH grants. All other authors declare no competing interests.
Figures
References
-
- Potvin O, Dieumegarde L, Duchesne S, et al. NOMIS: quantifying morphometric deviation from normality over the lifetime in the adult human brain. bioRxiv 2022; published online Feb 23. doi: 10.1101/2021.01.25.428063 (preprint). - DOI
-
- Villalon-Reina JE, Moreau CA, Nir TM, et al. Multi-site normative modeling of diffusion tensor imaging metrics using hierarchical Bayesian regression. In: Wang L, Dou Q, Fletcher P, Speidel S, Li S, editors. Medical Image Computing and Computer Assisted Intervention – MICCAI 2022. MICCAI 2022 Lecture Notes in Computer Science. Springer, Cham: 2022; 13431: 207–17. - PMC - PubMed
Publication types
Grants and funding
- U24 DA041147/DA/NIDA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- R01 AG067420/AG/NIA NIH HHS/United States
- R01 MH104284/MH/NIMH NIH HHS/United States
- R01 MH116147/MH/NIMH NIH HHS/United States
- R01 MH113619/MH/NIMH NIH HHS/United States
- T32 MH122394/MH/NIMH NIH HHS/United States
- U54 EB020403/EB/NIBIB NIH HHS/United States
- R01 HD050735/HD/NICHD NIH HHS/United States
- UL1 TR004419/TR/NCATS NIH HHS/United States
- UL1 TR000153/TR/NCATS NIH HHS/United States
- R01 CA101318/CA/NCI NIH HHS/United States
- P30 AG072976/AG/NIA NIH HHS/United States
- U24 RR025736/RR/NCRR NIH HHS/United States
- R01 AG019771/AG/NIA NIH HHS/United States
- UL1 RR025761/RR/NCRR NIH HHS/United States
- P50 HD105351/HD/NICHD NIH HHS/United States
- R01 MH117014/MH/NIMH NIH HHS/United States
- R01 MH042191/MH/NIMH NIH HHS/United States
- U24 RR021992/RR/NCRR NIH HHS/United States
- R01 MH090553/MH/NIMH NIH HHS/United States
- RC2 DA029475/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources